Cargando…

Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice

Idiosyncratic drug-induced liver injury (DILI) is a type of hepatic injury caused by an uncommon drug adverse reaction that can develop to conditions spanning from asymptomatic liver laboratory abnormalities to acute liver failure (ALF) and death. The cellular and molecular mechanisms involved in DI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Villanueva-Paz, Marina, Morán, Laura, López-Alcántara, Nuria, Freixo, Cristiana, Andrade, Raúl J., Lucena, M Isabel, Cubero, Francisco Javier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000729/ https://www.ncbi.nlm.nih.gov/pubmed/33807700 http://dx.doi.org/10.3390/antiox10030390

Ejemplares similares

Biomarkers in DILI: One More Step Forward
por: Robles-Díaz, Mercedes, et al.
Publicado: (2016)

Preclinical models of idiosyncratic drug-induced liver injury (iDILI): Moving towards prediction
por: Segovia-Zafra, Antonio, et al.
Publicado: (2021)

Genetic variations in drug-induced liver injury (DILI): resolving the puzzle
por: Stephens, Camilla, et al.
Publicado: (2012)

The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative
por: Bessone, Fernando, et al.
Publicado: (2016)

A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
por: Björnsson, Einar S., et al.
Publicado: (2022)

Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries
por: Bessone, Fernando, et al.
Publicado: (2022)

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery
por: Peta, Valentina, et al.
Publicado: (2017)

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials
por: Hey-Hadavi, Juliana, et al.
Publicado: (2021)

Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes
por: Quintás, Guillermo, et al.
Publicado: (2021)

The DILI‐sim Initiative: Insights into Hepatotoxicity Mechanisms and Biomarker Interpretation
por: Watkins, Paul B.
Publicado: (2019)

The Promise of AI for DILI Prediction
por: Vall, Andreu, et al.
Publicado: (2021)

Clinical management of patients with drug‐induced liver injury (DILI)
por: Björnsson, Einar S.
Publicado: (2021)

Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development
por: Roth, Sharin E., et al.
Publicado: (2019)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment
por: Moreno-Torres, Marta, et al.
Publicado: (2022)

Models of Drug Induced Liver Injury (DILI) – Current Issues and Future Perspectives
por: Kuna, Lucija, et al.
Publicado: (2018)

Mechanism of idiosyncratic drug induced liver injury (DILI): unresolved basic issues
por: Teschke, Rolf, et al.
Publicado: (2021)

Comment: Drug-Induced Liver Injury (DILI) With Micafungin: The Importance of Causality Assessment
por: Danjuma, Mohammed, et al.
Publicado: (2020)

Role of Hepatocyte Transporters in Drug-Induced Liver Injury (DILI)—In Vitro Testing
por: Tátrai, Péter, et al.
Publicado: (2022)

Mechanistic Studies of Idiosyncratic DILI: Clinical Implications
por: Uetrecht, Jack
Publicado: (2019)

Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2019)

The rediscovery of HepG2 cells for prediction of drug induced liver injury (DILI)
por: Ghallab, Ahmed
Publicado: (2014)

Prediction and mechanistic analysis of drug-induced liver injury (DILI) based on chemical structure
por: Liu, Anika, et al.
Publicado: (2021)

DILI( C ): An AI-Based Classifier to Search for Drug-Induced Liver Injury Literature
por: Rathee, Sanjay, et al.
Publicado: (2022)

Extracellular vesicles in liver disease and beyond
por: Morán, Laura, et al.
Publicado: (2018)

Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILI
por: Stern, Sydney, et al.
Publicado: (2023)

Infliximab (IFX)-Biosimilar Induced Drug-Induced Liver Injury (DILI): A Case Report
por: Zachou, Maria, et al.
Publicado: (2022)

Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions
por: Villanueva-Paz, Marina, et al.
Publicado: (2021)

Factors limiting immunization coverage in urban Dili, Timor-Leste
por: Amin, Ruhul, et al.
Publicado: (2013)

Landscape of DILI-related adverse drug reaction in China Mainland
por: Wang, Jiabo, et al.
Publicado: (2022)

The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development
por: Walker, Paul A., et al.
Publicado: (2020)

Machine-Learning Prediction of Oral Drug-Induced Liver Injury (DILI) via Multiple Features and Endpoints
por: Liu, Xiaobin, et al.
Publicado: (2020)

Characteristics of Drug-induced Liver Injury in Chronic Liver Disease: Results from the Thai Association for the Study of the Liver (THASL) DILI Registry
por: Chirapongsathorn, Sakkarin, et al.
Publicado: (2023)

Causality Assessment for Suspected DILI During Clinical Phases of Drug Development
por: Regev, Arie, et al.
Publicado: (2014)

2409. Drug-Induced Liver Injury (DILI) in a National Cohort of Hospitalized Patients Treated With Aztreonam and Ceftazidime
por: Saade, Elie, et al.
Publicado: (2018)

Liver Fibrosis Helps to Distinguish Autoimmune Hepatitis from DILI with Autoimmune Features: A Review of Twenty Cases
por: Febres-Aldana, Christopher A., et al.
Publicado: (2019)

A novel quantitative computer-assisted drug-induced liver injury causality assessment tool (DILI-CAT)
por: Tillmann, Hans L., et al.
Publicado: (2022)

Global publication trends and hotspots of molecular biomarkers in DILI from 1991 to 2020: A 30-year bibliometric analysis
por: Cao, Mingnan, et al.
Publicado: (2021)

Avoidability of drug-induced liver injury (DILI) in an elderly hospital cohort with cases assessed for causality by the updated RUCAM score
por: Danjuma, Mohammed Ibn-Mas’ud, et al.
Publicado: (2020)

Mechanistic Modeling Reveals the Critical Knowledge Gaps in Bile Acid–Mediated DILI
por: Woodhead, J L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_c9j9nct4tvhdilvlutdobs7j29